Availability of data and material
N/A.
Code availability
N/A.
References
Powers WJ, Rabinstein AA, Ackerson T et al (2019) Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American heart association/American stroke association [published correction appears in Stroke. 2019 Dec, 50(12), pp. e440–e441]. Stroke 50:e344–e418
Berge E, Whiteley W, Audebert H et al (2021) European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke. Eur Stroke J 6(1):I–LXII
Yaghi S, Willey JZ, Cucchiara B et al (2017) Treatment and outcome of hemorrhagic transformation after intravenous alteplase in acute ischemic stroke: a scientific statement for healthcare professionals from the american heart association/American stroke association. Stroke 48(12):e343–e361
Kneihsl M, Enzinger C, Wünsch G et al (2016) Poor short-term outcome in patients with ischaemic stroke and active cancer. J Neurol 263:150–156
Newton HB (1999) Neurologic complications of systemic cancer [published correction appears in Am Fam Physician 1999 May 1;59(9):2435]. Am Fam Physician 59:878–886
Grisold W, Oberndorfer S, Struhal W (2009) Stroke and cancer: a review. Acta Neurol Scand 119:1–16
Dardiotis E, Aloizou AM, Markoula S, Siokas V, Tsarouhas K, Tzanakakis G et al (2019) Cancer-associated stroke: pathophysiology, detection and management (Review). Int J Oncol 54:779–796
Lee AY, Levine MN, Baker RI et al (2003) Randomized comparison of low-molecular-weight heparin versus oral anticoagulant therapy for the prevention of recurrent venous thromboembolism in patients with cancer (CLOT) investigators. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med. 349(2):146–53
Ladak AA, Sandhu S, Itrat A (2021) Use of intravenous thrombolysis in acute ischemic stroke management in patients with active malignancies: a topical review. J Stroke Cerebrovasc Dis. 30(6):105728. https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.105728 (Epub 2021 Mar 18. PMID: 33743410)
Eikelboom JW, Connolly SJ, Bosch J, Shestakovska O, Aboyans V, Alings M, Anand SS, Avezum A, Berkowitz SD, Bhatt DL, Cook-Bruns N, Felix C, Fox KAA, Hart RG, Maggioni AP, Moayyedi P, O’Donnell M, Rydén L, Verhamme P, Widimsky P, Zhu J, Yusuf S (2019) Bleeding and new cancer diagnosis in patients with atherosclerosis. Circulation 140:1451–1459
Rumalla K, Mittal MK (2016) Gastrointestinal bleeding in acute ischemic stroke: a population-based analysis of hospitalizations in the United States. J Stroke Cerebrovasc Dis 25:1728–1735
Yoo J, Nam HS, Kim YD, Lee HS, Heo JH (2019) Stroke. Short-term outcome of ischemic stroke patients with systemic malignancy 50:507–511
Thomalla G, Simonsen CZ, Boutitie F et al (2018) WAKE-UP Investigators. MRI-guided thrombolysis for stroke with unknown time of onset. N Engl J Med. 379(7):611–622. https://doi.org/10.1056/NEJMoa1804355 (Epub 2018 May 16. PMID: 29766770)
Ma H, Campbell BCV, Parsons MW et al (2019) EXTEND investigators. Thrombolysis guided by perfusion imaging up to 9 hours after onset of stroke. N Engl J Med. 380(19):1795–1803. https://doi.org/10.1056/NEJMoa1813046 (Erratum in: N Engl J Med. 2021 Apr 1;384(13):1278. PMID: 31067369)
Benedict CR, Refino CJ, Keyt BA et al (1995) New variant of human tissue plasminogen activator (tpa) with enhanced efficacy and lower incidence of bleeding compared with recombinant human tpa. Circulation 92:3032–3040
Author information
Authors and Affiliations
Contributions
MGM conceptualized and supervised the manuscript; wrote, edited, and finalized the manuscript.
AC conceptualized and supervised the manuscript; wrote, edited, and finalized the manuscript.
PP edited and finalized the manuscript.
VC edited and finalized the manuscript.
MP conceptualized and supervised the manuscript; wrote, edited, and finalized the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Ethics approval
The study was approved by the pertinent institutional review board.
Informed consent
Informed consent was obtained from all patients.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Mosconi, M.G., Capponi, A., Pierini, P. et al. Safety and efficacy of intravenous thrombolysis in patients with acute stroke and active cancer: retrospective cohort study. Neurol Sci 43, 4003–4006 (2022). https://doi.org/10.1007/s10072-022-06026-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-022-06026-7